Chad Mendes Suspended For 2 Years For Failed Drug Test
Back on June 10th, it was announced that UFC featherweight Chad Mendes was flagged for a potential out-of-competition drug test violation by USADA, the UFC’s anti-doping partner.
As usual, USADA does not reveal what fighters tested positive for or specifically what the violation is. After remaining silent for nearly two week after the infraction, Chad Mendes released this brief statement via his official Twitter account:
“I didn’t do my homework and that was a big mistake. I own it and I’m going to pay for it.”
Today, USADA handed Mendes a 2-year suspension for the drug test failure, and since his punishment had been given, revealed via their website what substance he tested positive for. Here’s what they said:
“USADA announced today that UFC athlete Chad Mendes, of Sacramento, Calif., has received a two-year sanction for an anti-doping policy violation after testing positive for a prohibited substance.
Mendes, 31, tested positive for GHRP-6 (Growth Hormone-Releasing Hexapeptide) following an out-of-competition urine test conducted on May 17, 2016. GHRP-6 is a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.”
The tw0-year suspension is backdated to June 10th, 2016 – which makes Mendes eligible to return on June 10th, 2018. At 31-years of age, it’s likely that Mendes will resume his MMA career after the suspension. As of yet, Mendes has not commented on the suspension.